Literature DB >> 32170364

[Value and formats of quality assurance : Ophthalmology and intravitreal therapy between reality and wishful thinking].

Nicole Eter1, Daniel Pauleikhoff2,3, Hansjürgen Agostini4, Monika Fleckenstein5,6, Focke Ziemssen7.   

Abstract

BACKGROUND: In view of the large number of patients and error-prone activities, legal requirements for quality assurance (QA) are of great importance for modern ophthalmology.
OBJECTIVE: This article discusses the need and formats of QA using the example of intravitreal operative medication injection therapy (IVOM).
MATERIAL AND METHODS: The legal framework conditions are briefly referenced and improvement potentials of the status quo are discussed.
RESULTS: The first quality control instruments were implemented for IVOM therapy; however, important quality indicators (number of treatments per patient/year, loss of follow-up, course of function) are not yet evaluated nationwide in Germany and cannot therefore be taken into account for continuous improvement and QA reports. To date, not all ophthalmologists involved have been under review in the field of basic diagnostics and follow-up. Limiting QA to ophthalmic surgeons alone does not improve quality and many statutory health insurances actively prevent scientific investigations within selective contracts.
CONCLUSION: For the QA of imaging diagnostics, similar proficiency measures (random samples, round robin testing) are required in ophthalmology as in radiological disciplines. The communication of transparent quality indicators can reduce the risk in the medium term. The quality of treatment and results must not be left to chance, cost pressure or convenience. The manufacturers of software and diagnostic equipment should be oriented towards radiology, where the exchange of voxel-oriented image formats is now less and less hindered by proprietary formats.

Entities:  

Keywords:  Automatic analysis; Benchmarking; Data transfer; Quality indicators; Statement certainty

Mesh:

Year:  2020        PMID: 32170364     DOI: 10.1007/s00347-020-01064-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  36 in total

1.  The public release of performance data: what do we expect to gain? A review of the evidence.

Authors:  M N Marshall; P G Shekelle; S Leatherman; R H Brook
Journal:  JAMA       Date:  2000-04-12       Impact factor: 56.272

2.  Physician-patient communication. A key to malpractice prevention.

Authors:  W Levinson
Journal:  JAMA       Date:  1994 Nov 23-30       Impact factor: 56.272

3.  End the postcode lottery for cataract surgery.

Authors:  Michael Burdon
Journal:  BMJ       Date:  2019-05-28

4.  Risk factors for refractive error after cataract surgery: Analysis of 282 811 cataract extractions reported to the European Registry of Quality Outcomes for cataract and refractive surgery.

Authors:  Mats Lundström; Mor Dickman; Ype Henry; Sonia Manning; Paul Rosen; Marie-José Tassignon; David Young; Ulf Stenevi
Journal:  J Cataract Refract Surg       Date:  2018-04-22       Impact factor: 3.351

5.  [Who visits an ophthalmologist and how often? Results of the German nationwide adult health survey (DEGS1)].

Authors:  A K Schuster; C Wolfram; B Bertram; N Pfeiffer
Journal:  Ophthalmologe       Date:  2018-12       Impact factor: 1.059

Review 6.  [Legal aspects of quality assurance : Example of operative intravitreal injection therapy].

Authors:  Reinhold Preißler; Eva Hansmann; Klaus-Dieter Schnarr; Bernd Bertram; Focke Ziemssen
Journal:  Ophthalmologe       Date:  2020-04       Impact factor: 1.059

Review 7.  Patient-centred measurement in ophthalmology--a paradigm shift.

Authors:  Konrad Pesudovs
Journal:  BMC Ophthalmol       Date:  2006-06-15       Impact factor: 2.209

8.  Leveraging uncertainty information from deep neural networks for disease detection.

Authors:  Christian Leibig; Vaneeda Allken; Murat Seçkin Ayhan; Philipp Berens; Siegfried Wahl
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

Review 9.  External Quality Assessment beyond the analytical phase: an Australian perspective.

Authors:  Tony Badrick; Stephanie Gay; Euan J McCaughey; Andrew Georgiou
Journal:  Biochem Med (Zagreb)       Date:  2017-02-15       Impact factor: 2.313

10.  Diabetic retinopathy screening in incident diabetes mellitus type 2 in Germany between 2004 and 2013 - A prospective cohort study based on health claims data.

Authors:  Daniel Kreft; Myra B McGuinness; Gabriele Doblhammer; Robert P Finger
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.